MRC1 and glioblastoma: Intracranial tumors initiated by fibulin-3–deficient GBM cells showed increased presence of TAMs with decreased immunosuppression markers (arginase-1, CD206), whereas the opposite effects were observed in tumors overexpressing fibulin-3.